Lite Strategy, Inc. (LITS): Shareholders' Equity
$16.93M
As of 2025-06-30
$56.84M
As of 2026-03-31
-31.4%
3-year compound annual growth
-26.1%
5-year compound annual growth
-11.9%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-06-30 | $16.93M | -48.7% | 2025-09-26, Balance as of period end |
| 2024-06-30 | $33.02M | +34.1% | 2025-09-26, Balance as of period end |
| 2023-06-30 | $24.62M | -53.0% | 2025-09-26, Balance as of period end |
| 2022-06-30 | $52.41M | +6.0% | 2023-09-26, Balance as of period end |
| 2021-06-30 | $49.47M | -35.8% | 2022-09-08, Balance as of period end |
| 2020-06-30 | $77.06M | +60.8% | 2022-09-08, Balance as of period end |
| 2019-06-30 | $47.93M | -5.0% | 2022-05-23, Balance as of period end |
| 2018-06-30 | $50.46M | -0.7% | 2020-09-09, Balance as of period end |
| 2017-06-30 | $50.84M | +22.1% | 2019-08-28, Balance as of period end |
| 2016-06-30 | $41.65M | -30.3% | 2018-08-30, Balance as of period end |
| 2015-06-30 | $59.79M | +32.3% | 2017-09-05, Balance as of period end |
| 2014-06-30 | $45.19M | +29.6% | 2016-09-06, Balance as of period end |
| 2013-06-30 | $34.87M | +658.3% | 2015-09-02, Balance as of period end |
| 2012-06-30 | $4.60M | +156.4% | 2014-09-09, Balance as of period end |
| 2011-06-30 | $1.79M | -75.7% | 2013-09-18, Balance as of period end |
| 2010-06-30 | $7.38M | -51.5% | 2013-09-18, Balance as of period end |
| 2009-06-30 | $15.21M | -8.0% | 2013-09-18, Balance as of period end |
| 2008-06-30 | $16.54M | +20.0% | 2013-09-18, Balance as of period end |
| 2007-06-30 | $13.78M | +50.8% | 2013-09-18, Balance as of period end |
| 2006-06-30 | $9.13M | -44.7% | 2013-09-18, Balance as of period end |
| 2005-06-30 | $16.52M | -28.0% | 2013-09-18, Balance as of period end |
| 2004-06-30 | $22.94M | +286.7% | 2013-09-18, Balance as of period end |
| 2003-06-30 | $5.93M | -33.3% | 2013-09-18, Balance as of period end |
| 2002-06-30 | $8.90M | n/a | 2013-09-18, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | 2025-06-30 | $16.93M | -48.7% |
| Abbott Laboratories (ABT) | 2025-12-31 | $52.13B | +9.4% |
| Bristol Myers Squibb Co (BMY) | 2025-12-31 | $18.47B | +13.1% |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | $26.88M | -1.8% |
| Eli Lilly & Co (LLY) | 2025-12-31 | $26.54B | +85.9% |
| Pfizer Inc (PFE) | 2025-12-31 | $86.78B | -1.9% |
| Johnson & Johnson (JNJ) | 2025-12-28 | $81.54B | +14.1% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $161.55M | +0.3% |
| Merck & Co., Inc. (MRK) | 2025-12-31 | $52.66B | +13.6% |
Compare LITS, ABT, BMY, TXMD side by side · Screen every company in Pharmaceutical Preparations ↗